BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 28365939)

  • 1. HVEM in acute lymphocytic leukemia facilitates tumour immune escape by inhibiting CD8
    Liu Y; Wang L; Li Y; Zhong C; Wang X; Wang X; Xia Z; Liao J; Huang C; Mao C; Feng Y; Luo C; Mai W; Song H; Li H; Bao L; Chen D; Sheng Y; Zhang H; Wei X; Chen J; Yi W
    Cell Oncol (Dordr); 2024 May; ():. PubMed ID: 38809326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic deletion of HVEM in a leukemia B cell line promotes a preferential increase of PD-1
    Del Rio ML; de Juan CY; Roncador G; Caleiras E; Álvarez-Esteban R; Pérez-Simón JA; Rodriguez-Barbosa JI
    Front Immunol; 2023; 14():1113858. PubMed ID: 37033927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Cell-Intrinsic BTLA Receptor Inhibits the Proliferation of Tumor Cells via ERK1/2.
    Cheng TY; Liu YJ; Yan H; Xi YB; Duan LQ; Wang Y; Zhang TT; Gu YM; Wang XD; Wu CX; Gao S
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Features of Checkpoint Receptor-Ligand Interaction in Cancer and the Therapeutic Effectiveness of Their Inhibition.
    Kuzevanova A; Apanovich N; Mansorunov D; Korotaeva A; Karpukhin A
    Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Urinomic Identification of Protein Alternatives to Creatinine Normalization for Diagnostic Assessment of Lupus Nephritis.
    Soomro S; Stanley S; Lei R; Saxena R; Petri M; Mohan C
    Front Immunol; 2022; 13():853778. PubMed ID: 35774777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.
    Chakraborty S; Carnazza M; Jarboe T; DeSouza N; Li XM; Moscatello A; Geliebter J; Tiwari RK
    Adv Exp Med Biol; 2021; 1350():33-66. PubMed ID: 34888843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of HVEM is associated with improved prognosis in intrahepatic cholangiocarcinoma.
    Ma B; Meng H; Tian Y; Wang Y; Song T; Zhang T; Wu Q; Cui Y; Li H; Zhang W; Li Q
    Oncol Lett; 2021 Jan; 21(1):69. PubMed ID: 33365080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy.
    Macpherson AM; Barry SC; Ricciardelli C; Oehler MK
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32937961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HVEM/HIF-1α promoted proliferation and inhibited apoptosis of ovarian cancer cells under hypoxic microenvironment conditions.
    Duan L; Tao J; Yang X; Ye L; Wu Y; He Q; Duan Y; Chen L; Zhu J
    J Ovarian Res; 2020 Apr; 13(1):40. PubMed ID: 32312328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma.
    Malissen N; Macagno N; Granjeaud S; Granier C; Moutardier V; Gaudy-Marqueste C; Habel N; Mandavit M; Guillot B; Pasero C; Tartour E; Ballotti R; Grob JJ; Olive D
    Oncoimmunology; 2019; 8(12):e1665976. PubMed ID: 31741766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of herpesvirus entry mediator expression in human hepatocellular carcinoma.
    Hokuto D; Sho M; Yamato I; Yasuda S; Obara S; Nomi T; Nakajima Y
    Eur J Cancer; 2015 Jan; 51(2):157-65. PubMed ID: 25468715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of SATB1 and BRMS1 in ovarian serous adenocarcinoma and its relationship with clinieopathological features].
    Zhao XL; Wang P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):82-5, 105. PubMed ID: 21355308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and role of glucose-regulated protein 78 in ovarian serous adenocarcinoma].
    Fan LM; Su J; Dong H; Wei M; Cui MH
    Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(9):659-62. PubMed ID: 23751742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of herpesvirus entry mediator (HVEM) in ovarian serous adenocarcinoma tissue.
    Fang Y; Ye L; Zhang T; He QZ; Zhu JL
    J BUON; 2017; 22(1):80-86. PubMed ID: 28365939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of THY1 gene in epithelial ovarian cancer].
    Zeng LQ; Peng ZL; Duan ZL
    Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):118-20. PubMed ID: 19538887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of PH Domain Leucine-rich Repeat Protein Phosphatase, Forkhead Homeobox Type O 3a and RAD51, and their Relationships with Clinicopathologic Features and Prognosis in Ovarian Serous Adenocarcinoma.
    Zhang J; Wang JC; Li YH; Wang RX; Fan XM
    Chin Med J (Engl); 2017 Feb; 130(3):280-287. PubMed ID: 28139510
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.